Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gabrielle N. Gaultier"'
Autor:
Gabrielle N. Gaultier, Brynn McMillan, Chad Poloni, Mandy Lo, Bing Cai, Jean J. Zheng, Hannah M. Baer, Hennady P. Shulha, Karen Simmons, Ana Citlali Márquez, Sofia R. Bartlett, Laura Cook, Megan K. Levings, Theodore Steiner, Inna Sekirov, James E. A. Zlosnik, Muhammad Morshed, Danuta M. Skowronski, Mel Krajden, Agatha N. Jassem, Manish Sadarangani
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older, spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin-converting enzyme 2 (ACE2) inhibition surrogate neutralization and
Externí odkaz:
https://doaj.org/article/b21ce8f9399a4f10afbf41b7b7c5bfbe
Autor:
Gabrielle N. Gaultier, Eli B. Nix, Joelle Thorgrimson, Douglas Boreham, William McCready, Marina Ulanova
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Despite the use of pneumococcal conjugate vaccines for pediatric immunization, North American Indigenous populations continue to experience high burden of pneumococcal infections. Naturally acquired antibodies, which can protect unvaccinated adults a
Externí odkaz:
https://doaj.org/article/e36078b7ff374adca59b594a74a56597
Publikováno v:
Pathogens and Immunity, Vol 2, Iss 1, Pp 34-49 (2017)
Background: We have recently found that lipooligosaccharide (LOS) isolated from encapsulated strains of Haemophilus influenzae (H. influenzae) has strong adjuvant, but diminished pro-inflammatory ability as compared to Escherichia coli lipopolysaccha
Externí odkaz:
https://doaj.org/article/260d03bf45d34a7c91d1179159f6e913
Publikováno v:
BMC Immunology, Vol 20, Iss 1, Pp 1-13 (2019)
BMC Immunology
BMC Immunology
Background While the 23-valent pneumococcal polysaccharide vaccine (PPV23) is routinely used in Canada and some other countries to prevent pneumococcal infection in adults with chronic kidney disease (CKD), patients develop a suboptimal antibody resp
Autor:
William McCready, Gabrielle N. Gaultier, Angele Desbiens, Marina Ulanova, Brenda Huska, Victoria Domonkos
Publikováno v:
Vaccine. 39(4)
Individuals with chronic kidney disease (CKD) are at high risk of pneumococcal infections and recommended to receive the 23-valent pneumococcal polysaccharide vaccine (PPV23). Although the 13-valent pneumococcal conjugate vaccine (PCV13) has been fou
Publikováno v:
Pathogens & Immunity
Pathogens and Immunity, Vol 2, Iss 1, Pp 34-49 (2017)
Pathogens and Immunity, Vol 2, Iss 1, Pp 34-49 (2017)
Background: We have recently found that lipooligosaccharide (LOS) isolated from encapsulated strains of Haemophilus influenzae ( H. influenzae ) has strong adjuvant, but diminished pro-inflammatory ability as compared to Escherichia coli lipopolysacc
Publikováno v:
Vaccine. 37(28)
Individuals suffering from severe chronic kidney disease (CKD) are immunocompromised and therefore highly susceptible to various infections including Haemophilus influenzae type a (Hia), an emerging pathogen in North American Indigenous populations.
Autor:
Marina Ulanova, Eli B. Nix, Joshua Choi, Gabrielle N. Gaultier, Raymond S. W. Tsang, Douglas R. Boreham, Christina Anthes, Andrew D. Cox, William McCready, Joelle Thorgrimson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201282 (2018)
PLoS ONE, Vol 13, Iss 8, p e0201282 (2018)
During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompe
Autor:
Andrew D. Cox, Eli B. Nix, William McCready, Gabrielle N. Gaultier, Marina Ulanova, Joshua Choi
Nontypeable Haemophilus influenzae (NTHi), a typical mucosal pathogen largely responsible for respiratory infections and pediatric otitis media, has been increasingly recognized as a significant cause of invasive disease, especially in immunocompromi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a6f2fbfff3f0f6f196ee4e41449f8b
https://doi.org/10.1016/j.vaccine.2015.02.060
https://doi.org/10.1016/j.vaccine.2015.02.060
Autor:
Eli B Nix, Joshua Choi, Christina Anthes, Gabrielle N Gaultier, Joelle Thorgrimson, Andrew D Cox, Raymond S W Tsang, William G McCready, Douglas Boreham, Marina Ulanova
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201282 (2018)
During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompe
Externí odkaz:
https://doaj.org/article/f5b186e643ef4ec7a8e8c5001ba1a445